Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 331 AL 345

Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease

Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Lozupone M, Santamato A, Zecca C, Barulli MR, Bellomo A, Pilotto A, Daniele A, Greco A, Logroscino G.

Biomed Res Int. 2016;2016:3245935. doi: 10.1155/2016/3245935. Epub 2016 Jun 26.

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

Chen P, Zhao W, Guo Y, Xu J, Yin M.

Biomed Res Int. 2016;2016:8090918. doi: 10.1155/2016/8090918. Epub 2016 Jun 27.

A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers

Fang M, Oremus M, Tarride JE, Raina P; Canadian Willingness-to-pay Study Group.

Health Qual Life Outcomes. 2016 Jul 18;14(1):105. doi: 10.1186/s12955-016-0510-y.

Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?

Stanley M, Macauley SL, Holtzman DM.

J Exp Med. 2016 Jul 25;213(8):1375-85. doi: 10.1084/jem.20160493. Epub 2016 Jul 18.

Meta-analysis of cyclooxygenase-2 (COX-2) 765G>C polymorphism and Alzheimer's disease

Su J, Wen S, Zhu J, Liu R, Yang J.

J Clin Neurosci. 2016 Sep;31:4-9. doi: 10.1016/j.jocn.2015.11.032. Epub 2016 Jul 18.

Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease

Deardorff WJ, Grossberg GT.

Expert Opin Pharmacother. 2016 Sep;17(13):1789-800. doi: 10.1080/14656566.2016.1215431. Epub 2016 Jul 29.

Executive functions in patients with Alzheimer's disease, type 2 diabetes mellitus patients and cognitively healthy older adults

Redondo MT, Beltrán-Brotóns JL, Reales JM, Ballesteros S.

Exp Gerontol. 2016 Oct;83:47-55. doi: 10.1016/j.exger.2016.07.013. Epub 2016 Jul 21.

Are Late-Onset Autosomal Dominant and Sporadic Alzheimer Disease "Separate but Equal"?

Ringman JM.

JAMA Neurol. 2016 Sep 1;73(9):1060-1. doi: 10.1001/jamaneurol.2016.1633.

Potential Therapeutic Effects of Oleuropein Aglycone in Alzheimer's Disease

Martorell M, Forman K, Castro N, Capó X, Tejada S, Sureda A.

Curr Pharm Biotechnol. 2016;17(11):994-1001. doi: 10.2174/1389201017666160725120656.

Functions of the Alzheimer's Disease Protease BACE1 at the Synapse in the Central Nervous System

Munro KM, Nash A, Pigoni M, Lichtenthaler SF, Gunnersen JM.

J Mol Neurosci. 2016 Nov;60(3):305-315. doi: 10.1007/s12031-016-0800-1. Epub 2016 Jul 25.

Old and new acetylcholinesterase inhibitors for Alzheimer's disease

Galimberti D, Scarpini E.

Expert Opin Investig Drugs. 2016 Oct;25(10):1181-7. doi: 10.1080/13543784.2016.1216972. Epub 2016 Aug 5.

Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks

Correia SC, Perry G, Moreira PI.

Biochim Biophys Acta. 2016 Oct;1862(10):1909-17. doi: 10.1016/j.bbadis.2016.07.010. Epub 2016 Jul 25.

Active Vaccines for Alzheimer Disease Treatment

Sterner RM, Takahashi PY, Yu Ballard AC.

J Am Med Dir Assoc. 2016 Sep 1;17(9):862.e11-5. doi: 10.1016/j.jamda.2016.06.009. Epub 2016 Jul 25.

[Some aspects of the immune system in the pathogenesis of Alzehimers disease]

Chmátalová Z, Skoumalová A.

Epidemiol Mikrobiol Imunol. 2016 Summer;65(2):79-84.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias